Ascorbic Acid Detoxification for Drug Withdrawal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating drug and alcohol addiction are slow, painful, and often ineffective in reducing withdrawal symptoms and cravings, while also neglecting the nutritional health of patients, leading to prolonged recovery times and increased health risks.
Innovation Solution
A method involving the sequential parenteral administration of different concentrations of ascorbic acid, along with vitamins, minerals, amino acids, and antioxidants to rapidly detoxify the body, reduce withdrawal symptoms, and restore nutritional health, using compositions that target and remove toxic compounds and free radicals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional maintenance programs using opioid analogs are used, then withdrawal symptoms are reduced, but the patient remains addicted to the analog drug
Solution Approach 1:
The patent extracts and eliminates the harmful dependency on substitute drugs by using opioid antagonist medications that block opioid receptors, preventing both the original drug and substitute drugs from producing effects. This extraction approach removes the addiction cycle entirely rather than replacing one drug with another.
Solution Approach 2:
The patent introduces intermediary substances (opioid antagonist medications) that mediate between the patient and the opioid system. These intermediaries block the effects of opioids without producing intoxication themselves, serving as a bridge that enables complete withdrawal without relapse to addiction.
2Reliability
If cold turkey withdrawal method is used, then complete detoxification is achieved, but severe physical pain and discomfort occur
Solution Approach 1:
The patent applies preliminary anti-action by administering opioid antagonist medications before and during the withdrawal process. These medications proactively block opioid receptors and prevent the development of severe withdrawal symptoms, including pain, anxiety, and depression, thereby enabling complete detoxification without suffering.
Solution Approach 2:
The patent uses intermediary medication that acts as a mediator between the cessation of opioid use and the patient's physical state. The antagonist medication smooths the withdrawal transition by continuously blocking opioid effects, eliminating the severe pain and discomfort that would otherwise occur during cold turkey withdrawal.
3Object-affected harmful factors
If sedatives and analgesics are used to reduce withdrawal symptoms, then comfort is improved, but the patient remains dependent on additional drugs
Solution Approach 1:
The patent extracts the dependency on additional medications by using a specific class of opioid antagonists that do not produce euphoria or dependence. These medications block opioid effects without creating new dependencies, allowing withdrawal symptom management without the harmful cycle of sedative and analgesic dependence.
Solution Approach 2:
The patent changes the pharmacological parameter by switching from agonist medications (which produce effects) to antagonist medications (which block effects). This parameter change fundamentally alters the mechanism of action, providing symptom relief through blockage rather than substitution, thereby eliminating the risk of new drug dependence.
4Object-affected harmful factors
If traditional detoxification programs are used, then withdrawal symptoms are managed, but nutritional health of patients is neglected
Solution Approach 1:
The patent merges the detoxification process with nutritional rehabilitation by combining opioid antagonist medication administration with comprehensive nutritional support. This integrated approach simultaneously manages withdrawal symptoms and restores nutritional health, addressing both aspects of recovery rather than treating them separately.
Solution Approach 2:
The patent applies a multi-functional treatment approach where the detoxification program simultaneously achieves multiple objectives: blocking opioid effects, managing withdrawal symptoms, providing nutritional support, and restoring physical health. This universal approach eliminates the neglect of nutritional health that characterizes traditional programs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for rapid detoxification within 4-7 hours with minimal withdrawal symptoms, effectively reducing cravings and promoting overall health, enabling quicker return to daily activities and reducing the risk of complications.
Implementation Method 1
compositions that target and remove toxic compounds and free radicals
Implementation Method 2
compositions that target and remove toxic compounds and free radicals
Data Source
AI summary
Methods and compositions of reducing or eliminating the symptoms of withdrawal from drug or alcohol in drug or alcohol-dependent persons, while restoring the patient to nutritional health. The methods including parenteral administration of solutions containing high doses of ascorbic acid; while the compositions of the invention comprise at least about 20% (w), or at least about 25% (w), or at least about 30% (w), or at least about 35% (w), or at least about 38% (w) of ascorbic acid and a local anesthetic.